Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Residual low ADC and high FA at the resection margin correlate with poor chemoradiation response and overall survival in high-grade glioma patients

(2016) Jinrong Qu et al.   EUROPEAN JOURNAL OF RADIOLOGY

The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas

(2016) Hao-Yuan Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Detection of 2-hydroxyglutarate in brain tumors by triple-refocusing MR spectroscopy at 3T in vivo

(2016) Zhongxu An et al.   MAGNETIC RESONANCE IN MEDICINE

Magnetic resonance analysis of malignant transformation in recurrent glioma

(2016) Llewellyn E. Jalbert et al.   NEURO-ONCOLOGY

Imaging Tumor Metabolism Using In Vivo Magnetic Resonance Spectroscopy

(2015) Yan Li et al.   CANCER JOURNAL

Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival

(2015) Valeria Cuccarini et al.   JOURNAL OF NEURO-ONCOLOGY

A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas

(2014) A. Hilario et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab

(2014) Qiuting Wen et al.   JOURNAL OF NEURO-ONCOLOGY

Multiparametric Characterization of Grade 2 Glioma Subtypes Using Magnetic Resonance Spectroscopic, Perfusion, and Diffusion Imaging

(2014) Wei Bian et al.   Translational Oncology

ADC Values and Prognosis of Malignant Astrocytomas: Does Lower ADC Predict a Worse Prognosis Independent of Grade of Tumor?—A Meta-Analysis

(2013) Maria Zulfiqar et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status

(2012) Andrea Romano et al.   EUROPEAN RADIOLOGY

MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas

(2011) I. S. Khayal et al.   NEURO-ONCOLOGY

Implementation of 3 T Lactate-Edited 3D 1H MR Spectroscopic Imaging with Flyback Echo-Planar Readout for Gliomas Patients

(2010) Ilwoo Park et al.   ANNALS OF BIOMEDICAL ENGINEERING

Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis

(2010) K. A. Jaeckle et al.   JOURNAL OF NEURO-ONCOLOGY

Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting

(2009) Gisele B. Caseiras et al.   EUROPEAN JOURNAL OF RADIOLOGY

Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas

(2009) Inas S. Khayal et al.   NMR IN BIOMEDICINE

Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy

(2008) Suja Saraswathy et al.   JOURNAL OF NEURO-ONCOLOGY

Prognostic value of choline and creatine in WHO grade II gliomas

(2008) Elke Hattingen et al.   NEURORADIOLOGY